Search
Ironwood Pharmaceuticals Inc
IRWDAdd to Watchlist
4.390USD
+0.160+3.78%
Close 07-31 16:00（ET）Quotes delayed by 15 min
722.65MMarket Cap
6.98P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Ironwood Pharmaceuticals Inc is 7.00, ranking 112 out of 155 in the Pharmaceuticals industry. The average price target is 3.00, with a high of 3.80 and a low of 0.70.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
6.350
Target Price
+50.12%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Ironwood Pharmaceuticals Inc
IRWD
4
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
Pfizer Inc
PFE
32
AbbVie Inc
ABBV
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Ironwood Pharmaceuticals Inc's expected revenue for the next quarter?
Ironwood Pharmaceuticals Inc's expected revenue is 114.84M.
What is Ironwood Pharmaceuticals Inc's price target?
Analysts forecast that Ironwood Pharmaceuticals Inc's price target is USD 3.00, with the highest forecast at USD 3.80 and the lowest forecast at USD 0.70.
How have Ironwood Pharmaceuticals IncIRWD's recent earnings per share performed?
The market expectation was USD 0.25, while Ironwood Pharmaceuticals IncIRWD's earnings per share (EPS) for the previous quarter was USD -0.02. EPS for the next quarter is expected at USD 0.36.
What is the analyst rating for Ironwood Pharmaceuticals Inc?
Based on the ratings of Ironwood Pharmaceuticals Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.